• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环细胞外囊泡作为心血管疾病诊断、预后和治疗中的生物标志物。

Circulating extracellular vesicles as biomarkers in the diagnosis, prognosis and therapy of cardiovascular diseases.

作者信息

Bernáth-Nagy Dominika, Kalinyaprak Melek Sükran, Giannitsis Evangelos, Ábrahám Pál, Leuschner Florian, Frey Norbert, Krohn Jona Benjamin

机构信息

Heart and Vascular Centre, Semmelweis University, Budapest, Hungary.

Department of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Heidelberg, Germany.

出版信息

Front Cardiovasc Med. 2024 Sep 2;11:1425159. doi: 10.3389/fcvm.2024.1425159. eCollection 2024.

DOI:10.3389/fcvm.2024.1425159
PMID:39314768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11417624/
Abstract

Cardiovascular disease (CVD) ranks among the primary contributors to worldwide mortality. Hence, the importance of constant research on new circulating biomarkers for the improvement of early diagnosis and prognostication of different CVDs and the development and refinement of therapeutic measures is critical. Extracellular vesicles (EV) have a great potential as diagnostic and prognostic markers, as they represent their parent cell by enclosing cell-specific molecules, which can differ in quality and quantity based on cell state. Assuming that all cell types of the cardiovascular system are capable of releasing EV into circulation, an emerging body of evidence has investigated the potential role of serum- or plasma-derived EV in CVD. Comprehensive research has unveiled alterations in EV quantity and EV-bound cargo in the form of RNA, proteins and lipids in the context of common CVDs such as coronary artery disease, atrial fibrillation, heart failure or inflammatory heart diseases, highlighting their diagnostic and prognostic relevance. In numerous and models, EV also showed promising therapeutic potential. However, translation of EV studies to a preclinical or clinical setting has proven to be challenging. This review is intended to provide an overview of the most relevant studies in the field of serum or plasma-derived EV.

摘要

心血管疾病(CVD)是全球死亡率的主要促成因素之一。因此,持续研究新的循环生物标志物对于改善不同心血管疾病的早期诊断和预后以及治疗措施的开发和完善至关重要。细胞外囊泡(EV)作为诊断和预后标志物具有巨大潜力,因为它们通过包裹细胞特异性分子来代表其母细胞,这些分子的质量和数量会因细胞状态而异。假设心血管系统的所有细胞类型都能够将EV释放到循环中,越来越多的证据研究了血清或血浆来源的EV在心血管疾病中的潜在作用。全面研究揭示了在常见心血管疾病(如冠状动脉疾病、心房颤动、心力衰竭或炎症性心脏病)的背景下,EV数量以及以RNA、蛋白质和脂质形式存在的与EV结合的货物的变化,突出了它们在诊断和预后方面的相关性。在众多体外和体内模型中,EV也显示出有前景的治疗潜力。然而,将EV研究转化为临床前或临床应用已被证明具有挑战性。本综述旨在概述血清或血浆来源的EV领域中最相关的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff8/11417624/53e27ba96110/fcvm-11-1425159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff8/11417624/53e27ba96110/fcvm-11-1425159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff8/11417624/53e27ba96110/fcvm-11-1425159-g001.jpg

相似文献

1
Circulating extracellular vesicles as biomarkers in the diagnosis, prognosis and therapy of cardiovascular diseases.循环细胞外囊泡作为心血管疾病诊断、预后和治疗中的生物标志物。
Front Cardiovasc Med. 2024 Sep 2;11:1425159. doi: 10.3389/fcvm.2024.1425159. eCollection 2024.
2
Metabolites as extracellular vesicle cargo in health, cancer, pleural effusion, and cardiovascular diseases: An emerging field of study to diagnostic and therapeutic purposes.代谢物作为健康、癌症、胸腔积液和心血管疾病中细胞外囊泡的货物:一个用于诊断和治疗目的的新兴研究领域。
Biomed Pharmacother. 2023 Jan;157:114046. doi: 10.1016/j.biopha.2022.114046. Epub 2022 Dec 2.
3
The good, the bad and the ugly: the impact of extracellular vesicles on the cardiovascular system.好的、坏的和丑的:细胞外囊泡对心血管系统的影响。
J Physiol. 2023 Nov;601(22):4837-4852. doi: 10.1113/JP282048. Epub 2022 Apr 12.
4
Circulating Extracellular Vesicles Are Strongly Associated With Cardiovascular Risk Markers.循环细胞外囊泡与心血管风险标志物密切相关。
Front Cardiovasc Med. 2022 May 26;9:907457. doi: 10.3389/fcvm.2022.907457. eCollection 2022.
5
SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128.SIV 感染调节循环血浆 miRNA 在细胞外囊泡(EVs)和细胞外凝聚物(ECs)中的区室化,并降低 EV 相关 miRNA-128。
Viruses. 2023 Feb 24;15(3):622. doi: 10.3390/v15030622.
6
Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles.评估基于珠粒的流式细胞仪平台在中枢神经系统来源细胞外囊泡的多参数表型分析中的技术和临床实用性。
Cell Commun Signal. 2023 Oct 6;21(1):276. doi: 10.1186/s12964-023-01308-9.
7
The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease.血浆细胞外囊泡在心血管疾病中的诊断和预后潜力。
Expert Rev Mol Diagn. 2015;15(12):1577-88. doi: 10.1586/14737159.2015.1109450. Epub 2015 Nov 4.
8
Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases.循环细胞外囊泡作为心血管疾病的生物标志物和药物递送载体
Biomolecules. 2021 Mar 5;11(3):388. doi: 10.3390/biom11030388.
9
Extracellular vesicles in the diagnosis and treatment of cardiovascular disease. What's behind? What do we need to implement them into clinical practice?细胞外囊泡在心血管疾病的诊断和治疗中的应用。背后有什么?我们需要做什么才能将其付诸临床实践?
Int J Biochem Cell Biol. 2024 Jul;172:106600. doi: 10.1016/j.biocel.2024.106600. Epub 2024 May 26.
10
Extracellular Vesicle MicroRNAs in Heart Failure: Pathophysiological Mediators and Therapeutic Targets.细胞外囊泡 microRNAs 在心力衰竭中的作用:病理生理介质和治疗靶点。
Cells. 2023 Aug 25;12(17):2145. doi: 10.3390/cells12172145.

引用本文的文献

1
Emerging Biomimetic Drug Delivery Nanoparticles Inspired by Extracellular Vesicles.受细胞外囊泡启发的新型仿生药物递送纳米颗粒
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Jul-Aug;17(4):e70025. doi: 10.1002/wnan.70025.
2
Extracellular Vesicles in cancer: from isolation and characterization to metastasis, drug resistance, and clinical applications.癌症中的细胞外囊泡:从分离、表征到转移、耐药性及临床应用
BMC Cancer. 2025 Jul 8;25(1):1154. doi: 10.1186/s12885-025-14375-7.
3
Diagnostic and prognostic roles of endothelial- and platelet-derived extracellular vesicles in cardiovascular diseases.

本文引用的文献

1
Comparative and integrated analysis of plasma extracellular vesicle isolation methods in healthy volunteers and patients following myocardial infarction.健康志愿者和心肌梗死后患者血浆细胞外囊泡分离方法的比较与综合分析
J Extracell Biol. 2022 Nov 23;1(11):e66. doi: 10.1002/jex2.66. eCollection 2022 Nov.
2
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.细胞外囊泡研究的最低信息要求(MISEV2023):从基础到先进方法。
J Extracell Vesicles. 2024 Feb;13(2):e12404. doi: 10.1002/jev2.12404.
3
Circulating Small Extracellular Vesicles Reflect the Severity of Myocardial Damage in STEMI Patients.
内皮细胞和血小板衍生的细胞外囊泡在心血管疾病中的诊断和预后作用。
J Transl Med. 2025 May 16;23(1):553. doi: 10.1186/s12967-025-06522-2.
循环微小细胞外囊泡反映 STEMI 患者心肌损伤的严重程度。
Biomolecules. 2023 Sep 29;13(10):1470. doi: 10.3390/biom13101470.
4
Circulating Exosomal CircRNAs as Diagnostic Biomarkers for Chronic Coronary Syndrome.循环外泌体环状RNA作为慢性冠状动脉综合征的诊断生物标志物
Metabolites. 2023 Oct 10;13(10):1066. doi: 10.3390/metabo13101066.
5
Exosomal circ-0020887 and circ-0009590 as novel biomarkers for the diagnosis and prediction of short-term adverse cardiovascular outcomes in STEMI patients.外泌体circ-0020887和circ-0009590作为ST段抬高型心肌梗死患者短期不良心血管结局诊断和预测的新型生物标志物。
Open Med (Wars). 2023 Oct 11;18(1):20230807. doi: 10.1515/med-2023-0807. eCollection 2023.
6
Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America.心力衰竭流行病学与结局统计:美国心力衰竭学会报告
J Card Fail. 2023 Oct;29(10):1412-1451. doi: 10.1016/j.cardfail.2023.07.006. Epub 2023 Sep 26.
7
Intracoronary delivery of extracellular vesicles from human cardiac progenitor cells reduces infarct size in porcine acute myocardial infarction.人心脏祖细胞来源的细胞外囊泡冠状动脉内递送可减小猪急性心肌梗死的梗死面积。
Eur Heart J. 2024 Mar 1;45(9):728-732. doi: 10.1093/eurheartj/ehad636.
8
Serum‑derived exosomal hsa‑let‑7b‑5p as a biomarker for predicting the severity of coronary stenosis in patients with coronary heart disease and hyperglycemia.血清衍生的外泌体 hsa-let-7b-5p 作为预测冠心病合并高血糖患者冠状动脉狭窄严重程度的生物标志物。
Mol Med Rep. 2023 Nov;28(5). doi: 10.3892/mmr.2023.13090. Epub 2023 Sep 15.
9
2023 ESC Guidelines for the management of acute coronary syndromes.2023年欧洲心脏病学会急性冠状动脉综合征管理指南。
Eur Heart J. 2023 Oct 12;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191.
10
Red Blood Cells and Endothelium Derived Circulating Extracellular Vesicles in Health and Chronic Heart Failure: A Focus on Phosphatidylserine Dynamics in Vesiculation.红细胞和内皮细胞衍生的循环细胞外囊泡在健康和慢性心力衰竭中的作用:重点关注囊泡化过程中的磷脂酰丝氨酸动力学。
Int J Mol Sci. 2023 Jul 23;24(14):11824. doi: 10.3390/ijms241411824.